Tunable Amine Density Coatings for Scalable Diagnostic Arrays
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing immune-mediated disorders, autoimmune diseases, infections, and cancer face challenges due to misdiagnosis and the high cost, scalability issues, and poor reproducibility of protein and robotically printed peptide arrays.
Innovation Solution
Development of molecules and methods for creating scalable, cost-effective peptide arrays with specific binding patterns that utilize chemical libraries and orthogonal analytical methods like ellipsometry, mass spectrometry, and fluorescence to identify disease-specific antibody binding signatures, known as immunosignaturing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If protein and robotically printed peptide arrays are used for diagnosis, then binding patterns can be obtained, but the methods suffer from high cost, poor reproducibility, and scalability issues
Solution Approach 1:
The patent replaces mechanical robotic printing systems with chemical vapor deposition methods. The coating process uses chemical reactions in vapor phase to deposit amino-containing compounds uniformly across substrate surfaces, eliminating the need for mechanical positioning and printing operations. This substitution enables scalable production while maintaining consistent coating quality and amino group density across large numbers of substrates.
Solution Approach 2:
The patent systematically varies parameters such as amino-containing compound concentration, deposition time, temperature, and vapor pressure to optimize and control amino group density on substrate surfaces. By establishing parameter ranges and relationships, the method achieves reproducible results across different production scales, resolving the contradiction between reliability and productivity.
2Manufacturing precision
If amino group density is increased to improve binding characteristics, then binding patterns improve, but non-specific antibody binding may increase
Solution Approach 1:
The patent creates locally optimized coating properties by controlling amino group distribution and density in specific regions or layers. The multi-layer coating structures allow different layers to have different amino group densities, with surface layers optimized for specific binding and inner layers providing structural support or reduced non-specific binding. This local optimization enables improved binding characteristics while minimizing harmful non-specific interactions.
Solution Approach 2:
The patent introduces intermediary layers or blocking agents between the amino-containing coating and antibody targets. These intermediaries modulate the interaction by reducing non-specific binding while preserving specific binding characteristics. The intermediary layer acts as a filter that allows desired binding while blocking unwanted interactions, resolving the contradiction between binding strength and specificity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables reliable, low-cost, and scalable methods for constructing arrays that accurately diagnose disease states by minimizing non-specific antibody binding and optimizing amino group density for improved binding characteristics.
Implementation Method 1
The deposition reaction can comprise a chemical vapor deposition reaction
Implementation Method 2
The coating can be characterized by a water contact angle, thickness, and smoothness
Implementation Method 3
utilize chemical libraries and orthogonal analytical methods like ellipsometry, mass spectrometry, and fluorescence
Implementation Method 4
utilize chemical libraries and orthogonal analytical methods like ellipsometry, mass spectrometry, and fluorescence
Data Source
AI summary
Molecules or salts thereof are provided, having the structure in Formula I, wherein n2 and n4 are the same or different and are independently 1, 2, or 3, and n3 is 1 to 20; X is oxygen, nitrogen, or sulfur; wherein R1, R2, R3, R4, R5, R6, and R7 are as described herein. Methods are also provided for the synthesis of and use of the provided molecules in applications for diagnostic testing.